SYN-TECH Chem. & Pharm. Co., Ltd.

Research SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) on Bullrun: market cap TWD 3.42B, P/E 10.4, dividend yield 5.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 3.42B; P/E is 10.4; dividend yield is 5.2%.

Peer valuation comparison

Latest P/E is 10.35x versus a Healthcare sector median of 21.74x (52.4% below).

Latest dividend yield is 5.22% versus a Healthcare sector median of 2.4% (117.5% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 3.42B10.45.2%4

Dividend history

Latest trailing dividend snapshot: annual dividend/share 4 TWD, yield 5.2%.

About SYN-TECH Chem. & Pharm. Co., Ltd.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is SYN-TECH Chem. & Pharm. Co., Ltd.'s market cap?

SYN-TECH Chem. & Pharm. Co., Ltd.'s market capitalization is TWD 3.42B.

What is SYN-TECH Chem. & Pharm. Co., Ltd.'s P/E ratio?

SYN-TECH Chem. & Pharm. Co., Ltd.'s price-to-earnings (P/E) ratio is 10.4.

Does SYN-TECH Chem. & Pharm. Co., Ltd. pay a dividend?

SYN-TECH Chem. & Pharm. Co., Ltd. has a dividend yield of 5.2%.

What does SYN-TECH Chem. & Pharm. Co., Ltd. do?

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines.